Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and concanavalin a

daunorubicin has been researched along with concanavalin a in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19905 (62.50)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hattori, K; Kitao, T1
Diener, E; Diner, UE; Sinha, A; Vergidis, R; Xie, S1
Abe, T; Amano, K; Homma, M; Hosono, O; Koide, J; Masuho, Y; Morimoto, C; Takano, M; Takeuchi, T1
Chandra, P; Gericke, D1
Kataoka, T; Ogihara, K; Sakurai, Y1
Hosaka, K; Kadoya, T; Sugawara, K; Yugami, A1
Hosaka, K; Kadoya, T; Kuramitz, H; Sugawara, K; Yugami, A1
Kadoya, T; Kuramitz, H; Sugawara, K1

Other Studies

8 other study(ies) available for daunorubicin and concanavalin a

ArticleYear
Concanavalin A as a carrier of daunomycin.
    Nature, 1977, Jan-06, Volume: 265, Issue:5589

    Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Aggregation; Concanavalin A; Daunorubicin; Drug Combinations; Hydrocortisone; Leukemia L1210; Mice

1977
Specific immunosuppression by immunotoxins containing daunomycin.
    Science (New York, N.Y.), 1986, Jan-10, Volume: 231, Issue:4734

    Topics: Animals; Autoimmune Diseases; Concanavalin A; Daunorubicin; Fluorescein; Fluoresceins; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Mice; Mice, Inbred CBA; Nitrohydroxyiodophenylacetate; Ovalbumin; Picrates; Spleen; T-Lymphocytes

1986
DNA-daunorubicin complexes specifically suppress in vitro spontaneous anti-DNA antibody production in lymphocytes of patients with systemic lupus erythematosus.
    Arthritis and rheumatism, 1986, Volume: 29, Issue:10

    Topics: Antibodies, Antinuclear; Concanavalin A; Daunorubicin; DNA; DNA Adducts; Humans; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins

1986
Immunosuppressive activity of some new cytostatic agents.
    Zeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology, 1973, Jun-19, Volume: 79, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; BCG Vaccine; Chlorambucil; Concanavalin A; Daunorubicin; Doxorubicin; Friend murine leukemia virus; Hydroxyurea; Immunosuppressive Agents; Mannomustine; Mice; Mice, Inbred AKR; Spleen

1973
Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors.
    Cancer research, 1980, Volume: 40, Issue:10

    Topics: Animals; Concanavalin A; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Immunization; Immunotherapy; Leukemia L1210; Male; Mice; Mitomycins; Prognosis; T-Lymphocytes, Regulatory; Vaccines

1980
Electrochemically monitoring the binding of concanavalin A and ovalbumin.
    Talanta, 2011, Jul-15, Volume: 85, Issue:1

    Topics: Concanavalin A; Daunorubicin; Electrochemical Techniques; Molecular Probes; Ovalbumin; Protein Binding

2011
Electrochemical assay of concanavalin A-ovalbumin binding on magnetic beads.
    The Analyst, 2012, Aug-21, Volume: 137, Issue:16

    Topics: Concanavalin A; Daunorubicin; Electrochemistry; Immobilized Proteins; Magnets; Mannose; Microspheres; Ovalbumin; Particle Size; Protein Binding

2012
Electrochemical sensing of concanavalin A using a non-ionic surfactant with a maltose moiety.
    Analytica chimica acta, 2014, Mar-03, Volume: 814

    Topics: Concanavalin A; Daunorubicin; Electrochemical Techniques; Glucosides; Limit of Detection; Maltose; Micelles; Surface-Active Agents

2014